BIOMED-2 protocols to detect clonal immunoglobulin and T-cell receptor gene rearrangements in B- and T-cell lymphomas in southern Taiwan

Leukemia and Lymphoma

Volumn 51, Issue 4, 2010, Pages 650-655

  Chen, Yi Lin ^a   Su, Ih Jen ^a,b   Cheng, Hsieh Yin ^a   Chang, Kung Chao ^a   Lu, Cheng Chan ^a,c   Chow, Nan Haw ^a,c   Ho, Chung Liang ^a,c   Huang, Wenya ^a,c,d  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d Signal Transduction Research   (Taiwan)

Author keywords

B cell lymphoma; BIOMED 2; Clonality; Immunoglobulin gene; T cell lymphoma; T cell receptor gene

Indexed keywords

IMMUNOGLOBULIN; T LYMPHOCYTE RECEPTOR;

ARTICLE; B CELL LYMPHOMA; CLONAL VARIATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; GENE REARRANGEMENT; HETERODUPLEX ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOBLASTOMA; MAJOR CLINICAL STUDY; NK T CELL LYMPHOMA; PRIORITY JOURNAL; T CELL LYMPHOMA; TAIWAN; TUMOR DIFFERENTIATION;

CELL LINE, TUMOR; CLINICAL PROTOCOLS; CLONE CELLS; DNA MUTATIONAL ANALYSIS; GENE REARRANGEMENT, B-LYMPHOCYTE; GENE REARRANGEMENT, T-LYMPHOCYTE; GENES, T-CELL RECEPTOR; HUMANS; IMMUNOGLOBULINS; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL; POLYMERASE CHAIN REACTION; TAIWAN;

EID: 77953215981     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428191003660631     Document Type: Article

References (15)

1. Ludman H, Spear PW. Reed-Sternberg cells in the peripheral blood; report of case of Hodgkin's disease. Blood 1957; 12:189-192.
2. Mauch PM, Armitage JO, Coiffier B, Dalla-Favera R, Harris NL, editors. Non-Hodgkin's lymphomas. Philadelphia, PA: Lippincott Williams & Wilkins; 2004.
3. Rizvi MA, Evens AM, Tallman MS, Nelson BP, Rosen ST. T-cell non-Hodgkin lymphoma. Blood 2006;107:1255-1264.
4. Hennessy BT, Hanrahan EO, Daly PA. Non-Hodgkin lymphoma: an update. Lancet Oncol 2004;6:341-353.
5. McCurley TL, Macon WR. Diagnosis and classification of non-Hodgkin lymphomas. In: Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F, Glader B, editors. Wintrobe's clinical hematology. Philadelphia, PA: Lippincott Williams & Wilkins; 2004. pp 2301-2324.
6. Arnold A, Cossman J, Bakhshi A, Jaffe ES, Waldmann TA, Korsmeyer SJ. Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms. N Engl J Med 1983;309:1593-1599.
7. Trainor KJ, Brisco MJ, Story CJ, Morley AA. Monoclonality in B-lymphoproliferative disorders detected at the DNA level. Blood 1990;75:2220-2222.
8. Bertness V, Kirsch I, Hollis G, Johnson B, Bunn PAJ. T-cell receptor gene rearrangements as clinical markers of human T-cell lymphomas. N Engl J Med 1985;313:534-538.
9. Chuang SS, Lin CN, Shen FC, et al. Detecting clonal rearrangement in non-Hodgkin's lymphomas in Taiwan by polymerase chain reaction. LeukLymphoma 2003;44:117-121.
10. van Dongen JJ, Langerak AW, Brüggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;17:2257-2317.
11. van Krieken JH, Langerak AW,Macintyre EA, et al. Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia 2007;21:201-206.
12. Chuang SS, Lin CN, Li CY. Malignant lymphoma in southern Taiwan according to the revised European-American classification of lymphoid neoplasms. Cancer 2000;89:1586-1592.
13. Hirakawa S, Kuyama M, Takahashi S. Nasal and nasal-type natural killer/T-cell lymphoma. J Am Acad Dermatol 1999;40: 268-272.
14. Tsang WY, Chan JK, Ng CS, Pau MY. Utility of a paraffin section-reactive CD56 antibody (123C3) for characterization and diagnosis of lymphomas. Am J Surg Pathol 1996;20:202-210.
15. Bengtsson M, Tötterman TH, Smedmyr B, Festin R, Oberg G, Simonsson B. Regeneration of functional and activated NK and T sub-subset cells in the marrow and blood after autologous bone marrow transplantation: a prospective phenotypic study with 2/3-color FACS analysis. Leukemia 1989;3:68-75.